Table 2.
Druga | Range of drug concentrations used (μm) | CD |
BT/BM |
||||||
---|---|---|---|---|---|---|---|---|---|
n | Control (spikes/s)b | Drug (spikes/s)b | %Blockc | n | Control (spikes/s)b | Drug (spikes/s)b | %Blockc | ||
α9α10 nAChR antagonists | |||||||||
αBTX | 1–3 | 4 | 50.8 ± 9.6* | 45.2 ± 10.6* | 11 | 6 | −26.1 ± 3.7** | 0.6 ± 1.6 | 102** |
α-CtxRgIA | 0.3–1.67 | 3 | 48.6 ± 4.6** | 56.8 ± 5.3** | −17 | 12 | −26.9 ± 2.1** | −2.1 ± 3.1 | 92** |
ICS | 10 | 11 | 39.3 ± 4.8** | 27.3 ± 4.0** | 31** | 16 | −30.1 ± 2.4** | −1.0 ± 1.5 | 97** |
MLA | 0.1–3 | 3 | 47.2 ± 6.8* | 5.0 ± 1.6 | 89* | 11 | −26.6 ± 1.3** | −1.1 ± 0.8 | 96** |
Afferent nAChR antagonists | |||||||||
α-CtxMII | 1–2 | 6 | 43.1 ± 8.9** | 9.4 ± 2.7* | 78** | 6 | −26.3 ± 4.7** | −24.7 ± 4.7** | 6 |
bPiDDB | 0.1–3 | 11 | 44.0 ± 6.5** | −4.2 ± 2.2 | 110** | 5 | −30.4 ± 4.6** | −30.8 ± 4.8** | −1 |
DMPP | 5–20 | 27 | 51.1 ± 4.2** | −5.6 ± 2.3* | 109** | 10 | −22.1 ± 5.4** | −25.4 ± 3.4** | −15 |
5-iodo | 0.01–3 | 4 | 62.8 ± 19.7* | 4.8 ± 8.1 | 92* | 5 | −36.1 ± 7.0** | −35.5 ± 7.7** | 2 |
SazA | 0.01–3 | 5 | 41.4 ± 4.2** | −2.6 ± 2.8 | 106** | 5 | −36.1 ± 4.3** | −35.2 ± 3.2** | 2 |
Varenicline | 0.1–1 | 4 | 33.1 ± 8.6* | 3.9 ± 3.4 | 88* | 5 | −28.9 ± 4.2** | −29.5 ± 3.6** | −2 |
aDrug effects on average spike responses in CD and BT/BM afferents, taken from the first 100 ms interval immediately following the efferent shock train (20 shocks at 200/s). Drugs were classified as either α9α10 or afferent nAChR antagonists.
bMean discharge rate during shock train minus unstimulated background rate, before and after the indicated drug, respectively. Reported values are mean ± SEM in the absence (Control) and presence (Drug) of identified cholinergic agent. A one-sample t test was used to evaluate whether these means differed from zero; level of significance indicated by asterisk.
c100 * (1 − Drug/Control) where: 0–100%, drug response is smaller but of same sign as control response; >100%, drug response of opposite sign from control response; <0%, drug response larger but of same sign as control; statistical tests for %Block, paired t test between Drug and Control. For all statistical tests, asterisks indicate level of significance:
*p < 0.05;
**p < 0.01.